VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 27 filers reported holding VASCULAR BIOGENICS LTD in Q4 2017. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $1,133,000 | -35.8% | 185,726 | -53.2% | 0.03% | -32.5% |
| Q2 2017 | $1,765,000 | -19.8% | 396,726 | -0.8% | 0.04% | -24.5% |
| Q1 2017 | $2,200,000 | +13.4% | 400,000 | 0.0% | 0.05% | +8.2% |
| Q4 2016 | $1,940,000 | -7.1% | 400,000 | 0.0% | 0.05% | -18.3% |
| Q3 2016 | $2,088,000 | +13.2% | 400,000 | 0.0% | 0.06% | +17.6% |
| Q2 2016 | $1,844,000 | – | 400,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CVI Holdings, LLC | 1,896,902 | $4,173,000 | 5.19% |
| Knoll Capital Management, LLC | 896,771 | $1,973,000 | 1.68% |
| SABBY MANAGEMENT, LLC | 1,856,169 | $4,084,000 | 0.63% |
| 683 Capital Management, LLC | 346,574 | $762,000 | 0.05% |
| Virtu Financial LLC | 64,203 | $141,000 | 0.01% |
| Spark Investment Management LLC | 29,300 | $64,000 | 0.00% |
| Alyeska Investment Group, L.P. | 83,333 | $183,000 | 0.00% |
| Burt Wealth Advisors | 1,674 | $4,000 | 0.00% |
| A.R.T. Advisors, LLC | 24,682 | $54,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 29,220 | $64,000 | 0.00% |